Ataxia telangiectasia mutated kinase
Showing 1 - 25 of 3,009
NSCLC Trial in Pittsburgh (M1774, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Pittsburgh, PennsylvaniaUPMC Cancer Center
May 22, 2023
Ataxia Telangiectasia Trial in Lørenskog, Oslo (Nicotinamide ribonucleoside)
Active, not recruiting
- Ataxia Telangiectasia
- Nicotinamide ribonucleoside
-
Lørenskog, Norway
- +1 more
Aug 16, 2022
Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)
Recruiting
- Metastasis
- +2 more
- XRD-0394
- Palliative radiotherapy
-
Stanford, California
- +1 more
Sep 27, 2021
Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)
Not yet recruiting
- Breast Cancer
- M1774
- Fulvestrant injection
-
Marseille, FranceInstitut Paoli Calmettes
Aug 9, 2023
Ataxia Telangiectasia Trial in Nottingham (Magnetic Resonance Imaging and an optional blood test)
Not yet recruiting
- Ataxia Telangiectasia
- Magnetic Resonance Imaging and an optional blood test
-
Nottingham, United KingdomUniversity of Nottingham
May 31, 2022
Ataxia Telangiectasia in Children, Ataxia Telangiectasia Trial in Plymouth (Whole-body exercise and respiratory exercise)
Recruiting
- Ataxia Telangiectasia in Children
- Ataxia Telangiectasia
- Whole-body exercise and respiratory exercise
-
Plymouth, United KingdomUniversity of Plymouth
Jan 19, 2023
Soft Tissue Sarcoma Adult Trial in Amsterdam (AZD1390 + radiotherapy, AZD7648 + radiotherapy)
Recruiting
- Soft Tissue Sarcoma Adult
- AZD1390 + radiotherapy
- AZD7648 + radiotherapy
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Aug 29, 2022
Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme, Brain Tumors, Malignant Trial in United Kingdom, United
Recruiting
- Recurrent Glioblastoma Multiforme
- +3 more
- Radiation Therapy
- AZD1390
-
Boston, Massachusetts
- +8 more
Jul 15, 2022
Ataxia Telangiectasia Trial in Brisbane (Triheptanoin)
Not yet recruiting
- Ataxia Telangiectasia
- Triheptanoin
-
Brisbane, Queensland, AustraliaQueensland Children's Hospital
Feb 22, 2022
Pilot Study of Pancreatic Cancer Screening
Recruiting
- Pancreatic Carcinoma
- Biospecimen Collection
- +4 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Apr 13, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
- (no location specified)
Jan 14, 2023
A National Retrospective Population Based Cohort Study of
Active, not recruiting
- Ataxia Telangiectasia
-
Cambridge, Cambridgeshire, United Kingdom
- +1 more
Oct 11, 2021
Eye Movement Activity in an Ataxia Telangiectasia
Completed
- Ataxia Telangiectasia
- Dysmetria
-
Chéjov, Russian FederationClinical Rehabilitation Research Center "Russkoe pole"
Jul 20, 2022
Ataxia Telangiectasia, ATM Gene Mutation Trial in Nijmegen (Vitamin B3)
Completed
- Ataxia Telangiectasia
- ATM Gene Mutation
- Vitamin B3
-
Nijmegen, NetherlandsRadboudumc
Jul 21, 2022
Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell
Not yet recruiting
- Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +5 more
- Avelumab
- +6 more
- (no location specified)
Jul 13, 2023
Neurofilament Light- Chain in Ataxia Telangiectasia
Unknown status
- Ataxia Telangiectasia
- blood withdrawal
-
Frankfurt, Hessen, GermanyUniversity Children´s Hospital, Ped. Pulmonology
Oct 28, 2020
Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- combination therapy with no MEKi
- +3 more
- (no location specified)
Nov 29, 2022
Metastatic Non Small Cell Lung Cancer Trial in Australia, Singapore (Osimertinib, Stereotactic Radiosurgery (SRS))
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Osimertinib
- Stereotactic Radiosurgery (SRS)
-
Newcastle, New South Wales, Australia
- +12 more
Nov 16, 2022
NSCLC Trial in Beijing (Pyrotinib)
Recruiting
- Non-small Cell Lung Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College
Feb 20, 2023
Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- Elimusertib (BAY1895344)
- Pembrolizumab
-
Palo Alto, California
- +15 more
Jan 6, 2023
Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg
Active, not recruiting
- Metastatic Triple Negative Breast Cancer
- Olaparib Continuous (28-Day cycle) 300 mg BD.
- +2 more
-
Birmingham, Alabama
- +140 more
Nov 17, 2022